These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Molecular study of Fanconi anemia in Tunisia]. Bouchlaka C; Abdelhak S; Dellagi K; Tunis Med; 2004 May; 82(5):402-10. PubMed ID: 15453041 [TBL] [Abstract][Full Text] [Related]
25. Incidence of Fanconi anemia in children with congenital thumb anomalies referred for diepoxybutane testing. Webb ML; Rosen H; Taghinia A; McCarty ER; Cerrato F; Upton J; Labow BI J Hand Surg Am; 2011 Jun; 36(6):1052-7. PubMed ID: 21514743 [TBL] [Abstract][Full Text] [Related]
26. Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children. Svojgr K; Sumerauer D; Puchmajerova A; Vicha A; Hrusak O; Michalova K; Malis J; Smisek P; Kyncl M; Novotna D; Machackova E; Jencik J; Pycha K; Vaculik M; Kodet R; Stary J Eur J Med Genet; 2016 Mar; 59(3):152-7. PubMed ID: 26657402 [TBL] [Abstract][Full Text] [Related]
27. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2). McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993 [TBL] [Abstract][Full Text] [Related]
28. Two common founder mutations of the fanconi anemia group G gene FANCG/XRCC9 in the Japanese population. Yagasaki H; Oda T; Adachi D; Nakajima T; Nakahata T; Asano S; Yamashita T Hum Mutat; 2003 May; 21(5):555. PubMed ID: 12673805 [TBL] [Abstract][Full Text] [Related]
29. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor. Dewire MD; Ellison DW; Patay Z; McKinnon PJ; Sanders RP; Gajjar A Pediatr Blood Cancer; 2009 Dec; 53(6):1140-2. PubMed ID: 19530235 [TBL] [Abstract][Full Text] [Related]
30. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942 [TBL] [Abstract][Full Text] [Related]
31. Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutations. Tryon R; Zierhut H; MacMillan ML; Wagner JE Am J Med Genet A; 2017 Jan; 173(1):260-263. PubMed ID: 27714961 [TBL] [Abstract][Full Text] [Related]
32. A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations. Radulovic I; Schündeln MM; Müller L; Ptok J; Honisch E; Niederacher D; Wiek C; Scheckenbach K; Leblanc T; Larcher L; Soulier J; Reinhardt D; Schaal H; Andreassen PR; Hanenberg H Hum Mol Genet; 2023 May; 32(11):1836-1849. PubMed ID: 36721989 [TBL] [Abstract][Full Text] [Related]
33. Hepatoblastoma in a 4-year-old girl with Fanconi anaemia. Kopic S; Eirich K; Schuster B; Hanenberg H; Varon-Mateeva R; Rittinger O; Schimpl G; Schindler D; Jones N Acta Paediatr; 2011 May; 100(5):780-3. PubMed ID: 21138478 [TBL] [Abstract][Full Text] [Related]
34. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia. Radulovic I; Kuechler A; Schündeln MM; Paulussen M; von Neuhoff N; Reinhardt D; Hanenberg H Eur J Med Genet; 2021 Aug; 64(8):104260. PubMed ID: 34118472 [TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition. García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859 [TBL] [Abstract][Full Text] [Related]
36. Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling. Meyer S; Tischkowitz M; Chandler K; Gillespie A; Birch JM; Evans DG J Med Genet; 2014 Feb; 51(2):71-5. PubMed ID: 24259538 [TBL] [Abstract][Full Text] [Related]
37. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations. Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491 [TBL] [Abstract][Full Text] [Related]
38. Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia. Meyer S; Barber LM; White DJ; Will AM; Birch JM; Kohler JA; Ersfeld K; Blom E; Joenje H; Eden TO; Malcolm Taylor G Br J Haematol; 2006 May; 133(3):284-92. PubMed ID: 16643430 [TBL] [Abstract][Full Text] [Related]
39. Fanconi anemia and solid malignancies in childhood: a national retrospective study. Malric A; Defachelles AS; Leblanc T; Lescoeur B; Lacour B; Peuchmaur M; Maurage CA; Pierron G; Guillemot D; d'Enghien CD; Soulier J; Stoppa-Lyonnet D; Bourdeaut F Pediatr Blood Cancer; 2015 Mar; 62(3):463-70. PubMed ID: 25381700 [TBL] [Abstract][Full Text] [Related]
40. Endocrine abnormalities in patients with Fanconi anemia. Giri N; Batista DL; Alter BP; Stratakis CA J Clin Endocrinol Metab; 2007 Jul; 92(7):2624-31. PubMed ID: 17426088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]